Used in research and development for targeting the leptin receptor (LEPR/CD295) in metabolic and oncology studies. Shows potential in investigating obesity-related pathways and cancer therapies where LEPR signaling plays a role. Employed in flow cytometry, immunohistochemistry, and receptor binding assays to study receptor expression and function. Supports therapeutic antibody development by serving as a reference standard in preclinical evaluations.